Novo Nordisk

NOVOSEVEN RT

Manufacturer:

Novo Nordisk

Novoseven Rt HCPCS:

J7189

HCPCS Code Descriptor:

Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram

Category:

J Code

Novoseven Rt NDCs:

00169-7208-01, 00169-7205-01, 00169-7201-01, 00169-7202-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Novoseven Rt:

NOVOSEVEN RT is a Hematology drug manufactured by Novo Nordisk and administered via the Intravenous route of administration. The J Code: J7189 is aligned to the drug NOVOSEVEN RT.

ACCESS PRICING AND MORE BY REGISTERING

J7189 Added Date:

January 1, 2006

J7189 Effective Date:

January 1, 2021

J7189 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Novoseven Rt billing and coding information.
Novoseven Rt patient assistance information can be found through Novo Nordisk’s NovoCare at the URL: https://www.mynovosecure.com/resources.html
NOVOSEVEN RT prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for NOVOSEVEN RT. Please check back in a few weeks.